The global HIV therapy market, valued at $3.128 billion in 2025, is experiencing steady growth (3.6% CAGR) driven by increased prevalence, advanced treatments (Integrase Inhibitors, NRTIs), and improved access. Learn about key market trends, leading companies (Gilead, ViiV Healthcare), and regional insights.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
